139 related articles for article (PubMed ID: 14698623)
1. Use of fluorescence resonance energy transfer to study serpin-proteinase interactions.
Gettins PG; Olson ST
Methods; 2004 Feb; 32(2):110-9. PubMed ID: 14698623
[TBL] [Abstract][Full Text] [Related]
2. Comparative trajectories of active and S195A inactive trypsin upon binding to serpins.
Mellet P; Mély Y; Hedstrom L; Cahoon M; Belorgey D; Srividya N; Rubin H; Bieth JG
J Biol Chem; 2002 Oct; 277(41):38901-14. PubMed ID: 12077135
[TBL] [Abstract][Full Text] [Related]
3. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
Peterson FC; Gettins PG
Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
[TBL] [Abstract][Full Text] [Related]
4. Conformational distributions of protease-serpin complexes: a partially translocated complex.
Liu L; Mushero N; Hedstrom L; Gershenson A
Biochemistry; 2006 Sep; 45(36):10865-72. PubMed ID: 16953572
[TBL] [Abstract][Full Text] [Related]
5. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.
Olson ST; Bock PE; Kvassman J; Shore JD; Lawrence DA; Ginsburg D; Björk I
J Biol Chem; 1995 Dec; 270(50):30007-17. PubMed ID: 8530403
[TBL] [Abstract][Full Text] [Related]
6. alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition.
Dobó J; Gettins PG
J Biol Chem; 2004 Mar; 279(10):9264-9. PubMed ID: 14593107
[TBL] [Abstract][Full Text] [Related]
7. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
8. Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation.
Peterson FC; Gordon NC; Gettins PG
Biochemistry; 2000 Oct; 39(39):11884-92. PubMed ID: 11009600
[TBL] [Abstract][Full Text] [Related]
9. Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh.
Stratikos E; Gettins PG
J Biol Chem; 1998 Jun; 273(25):15582-9. PubMed ID: 9624149
[TBL] [Abstract][Full Text] [Related]
10. Use of NMR to study serpin function.
Gettins PG; Backovic M; Peterson FC
Methods; 2004 Feb; 32(2):120-9. PubMed ID: 14698624
[TBL] [Abstract][Full Text] [Related]
11. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.
Stratikos E; Gettins PG
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4808-13. PubMed ID: 10220375
[TBL] [Abstract][Full Text] [Related]
12. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
Egelund R; Petersen TE; Andreasen PA
Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
[TBL] [Abstract][Full Text] [Related]
13. The structure of a Michaelis serpin-protease complex.
Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
[TBL] [Abstract][Full Text] [Related]
14. Major proteinase movement upon stable serpin-proteinase complex formation.
Stratikos E; Gettins PG
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):453-8. PubMed ID: 9012804
[TBL] [Abstract][Full Text] [Related]
15. Determining serpin conformational distributions with single molecule fluorescence.
Mushero N; Gershenson A
Methods Enzymol; 2011; 501():351-77. PubMed ID: 22078542
[TBL] [Abstract][Full Text] [Related]
16. The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium.
Calugaru SV; Swanson R; Olson ST
J Biol Chem; 2001 Aug; 276(35):32446-55. PubMed ID: 11404362
[TBL] [Abstract][Full Text] [Related]
17. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
[TBL] [Abstract][Full Text] [Related]
18. Structure of a serpin-protease complex shows inhibition by deformation.
Huntington JA; Read RJ; Carrell RW
Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
[TBL] [Abstract][Full Text] [Related]
19. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.
Schreuder HA; de Boer B; Dijkema R; Mulders J; Theunissen HJ; Grootenhuis PD; Hol WG
Nat Struct Biol; 1994 Jan; 1(1):48-54. PubMed ID: 7656006
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
